Zoliget®

Zoliget®

Therapeutic Segment: Anti-Diabetic

Generic Name: Pioglitazone HCl + Glimepiride

Indication:

As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with a combination of pioglitazone and a sulfonylurea or whose diabetes is not adequately controlled with glimepiride alone, or for those patients who have initially responded to pioglitazone alone and require additional glycemic control.

Available as:

Tablets
  • 15MG + 2MG
  • 30MG + 2MG
  • 30MG + 4MG